505 related articles for article (PubMed ID: 18852012)
21. Arylamine N-acetyltransferases--from drug metabolism and pharmacogenetics to identification of novel targets for pharmacological intervention.
Sim E; Fakis G; Laurieri N; Boukouvala S
Adv Pharmacol; 2012; 63():169-205. PubMed ID: 22776642
[TBL] [Abstract][Full Text] [Related]
22. Polymorphic NATs and cancer predisposition.
Hirvonen A
IARC Sci Publ; 1999; (148):251-70. PubMed ID: 10493262
[TBL] [Abstract][Full Text] [Related]
23. Irreversible inactivation of arylamine N-acetyltransferases in the presence of N-hydroxy-4-acetylaminobiphenyl: a comparison of human and hamster enzymes.
Wang H; Wagner CR; Hanna PE
Chem Res Toxicol; 2005 Feb; 18(2):183-97. PubMed ID: 15720122
[TBL] [Abstract][Full Text] [Related]
24. 3D model of human arylamine N-acetyltransferase 2: structural basis of the slow acetylator phenotype of the R64Q variant and analysis of the active-site loop.
Rodrigues-Lima F; Dupret JM
Biochem Biophys Res Commun; 2002 Feb; 291(1):116-23. PubMed ID: 11829470
[TBL] [Abstract][Full Text] [Related]
25. Substrate selectivity of mouse N-acetyltransferases 1, 2, and 3 expressed in COS-1 cells.
Estrada-Rodgers L; Levy GN; Weber WW
Drug Metab Dispos; 1998 May; 26(5):502-5. PubMed ID: 9571233
[TBL] [Abstract][Full Text] [Related]
26. NMR-based model reveals the structural determinants of mammalian arylamine N-acetyltransferase substrate specificity.
Zhang N; Liu L; Liu F; Wagner CR; Hanna PE; Walters KJ
J Mol Biol; 2006 Oct; 363(1):188-200. PubMed ID: 16959263
[TBL] [Abstract][Full Text] [Related]
27. Human N-acetylation of benzidine: role of NAT1 and NAT2.
Zenser TV; Lakshmi VM; Rustan TD; Doll MA; Deitz AC; Davis BB; Hein DW
Cancer Res; 1996 Sep; 56(17):3941-7. PubMed ID: 8752161
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics and epidemiology of the NAT1 and NAT2 acetylation polymorphisms.
Hein DW; Doll MA; Fretland AJ; Leff MA; Webb SJ; Xiao GH; Devanaboyina US; Nangju NA; Feng Y
Cancer Epidemiol Biomarkers Prev; 2000 Jan; 9(1):29-42. PubMed ID: 10667461
[TBL] [Abstract][Full Text] [Related]
29. Structure and transcriptional regulation of the Nat2 gene encoding for the drug-metabolizing enzyme arylamine N-acetyltransferase type 2 in mice.
Boukouvala S; Price N; Plant KE; Sim E
Biochem J; 2003 Nov; 375(Pt 3):593-602. PubMed ID: 12904181
[TBL] [Abstract][Full Text] [Related]
30. The pharmacogenetics of NAT: structural aspects.
Pompeo F; Brooke E; Kawamura A; Mushtaq A; Sim E
Pharmacogenomics; 2002 Jan; 3(1):19-30. PubMed ID: 11966400
[TBL] [Abstract][Full Text] [Related]
31. Arylamine N-acetyltransferase I.
Minchin RF; Hanna PE; Dupret JM; Wagner CR; Rodrigues-Lima F; Butcher NJ
Int J Biochem Cell Biol; 2007; 39(11):1999-2005. PubMed ID: 17392017
[TBL] [Abstract][Full Text] [Related]
32. N-acetyltransferase 2 polymorphism in patients with diabetes mellitus.
Yalin S; Hatungil R; Tamer L; Ates NA; Dogruer N; Yildirim H; Karakas S; Atik U
Cell Biochem Funct; 2007; 25(4):407-11. PubMed ID: 16397907
[TBL] [Abstract][Full Text] [Related]
33. Molecular and Functional Characterization of N-Acetyltransferases NAT1 and NAT2 in Cynomolgus Macaque.
Uno Y; Murayama N; Yamazaki H
Chem Res Toxicol; 2018 Nov; 31(11):1269-1276. PubMed ID: 30358977
[TBL] [Abstract][Full Text] [Related]
34. Construction of Syrian hamster lines congenic at the polymorphic acetyltransferase locus (NAT2): acetylator genotype-dependent N- and O-acetylation of arylamine carcinogens.
Hein DW; Doll MA; Rustan TD; Gray K; Ferguson RJ; Feng Y
Toxicol Appl Pharmacol; 1994 Jan; 124(1):16-24. PubMed ID: 8291057
[TBL] [Abstract][Full Text] [Related]
35. Metabolic activation of N-hydroxyarylamines and N-hydroxyarylamides by 16 recombinant human NAT2 allozymes: effects of 7 specific NAT2 nucleic acid substitutions.
Hein DW; Doll MA; Rustan TD; Ferguson RJ
Cancer Res; 1995 Aug; 55(16):3531-6. PubMed ID: 7627960
[TBL] [Abstract][Full Text] [Related]
36. Arylamine N-acetyltransferases.
Sim E; Westwood I; Fullam E
Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):169-84. PubMed ID: 17428149
[TBL] [Abstract][Full Text] [Related]
37. Molecular genetics and function of NAT1 and NAT2: role in aromatic amine metabolism and carcinogenesis.
Hein DW
Mutat Res; 2002 Sep; 506-507():65-77. PubMed ID: 12351146
[TBL] [Abstract][Full Text] [Related]
38. The xenobiotic-metabolizing enzymes arylamine N-acetyltransferases in human lens epithelial cells: inactivation by cellular oxidants and UVB-induced oxidative stress.
Dairou J; Malecaze F; Dupret JM; Rodrigues-Lima F
Mol Pharmacol; 2005 Apr; 67(4):1299-306. PubMed ID: 15644493
[TBL] [Abstract][Full Text] [Related]
39. Arylamine N-acetyltransferase aggregation and constitutive ubiquitylation.
Liu F; Zhang N; Zhou X; Hanna PE; Wagner CR; Koepp DM; Walters KJ
J Mol Biol; 2006 Aug; 361(3):482-92. PubMed ID: 16857211
[TBL] [Abstract][Full Text] [Related]
40. N-acetyltransferase 2 (Nat2) polymorphism in the sand rat Psammomys obesus.
Khelil M; Djerdjouri B; Tayebi B
Toxicol Mech Methods; 2010 Oct; 20(8):440-4. PubMed ID: 20550432
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]